Ocular Therapeutix, Inc.OCULNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank31
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P31
Within normal range
vs 5Y Ago
-1.9x
Contraction
Streak
1 yr
Consecutive growthRecovering
PeriodValue
2025-59.52%
2024-78.15%
2023-20.54%
20225.13%
2021-22.70%
202031.85%
2019-56.15%
201812.96%
2017-63.49%
2016-1.12%